The Heart, Lung and Critical Care Clinical Group Board is a formal sub-committee of the Guy's and St Thomas' NHS Foundation Trust Board, with delegated responsibilities and decision-making rights for the strategic and operational running of its services. These are set out in the Guy’s and St Thomas’ Scheme of Delegation, and the Trust’s Standing Financial Instructions provide the delegation limits with regard to financial decisions.
The Guy’s and St Thomas’ NHS Foundation Trust Board of Directors holds legal accountability for the Trust including all aspects of the Heart, Lung and Critical Care Clinical Group. The clinical group Board provides assurance to the Guy’s and St Thomas’ NHS Foundation Trust Board of Directors on the overall operational, quality and safety and financial performance of the clinical group, and on the development and delivery of the Trust's strategy for its heart, lung and critical care services.
* voting member of the Guy’s and St Thomas’ Board
Avey returned to the Trust as Chief Nurse in November 2020, having trained as a critical care nurse at St Thomas' at the beginning of her career.
Avey qualified in 1991 and her clinical experience includes theatre, general intensive care, coronary care and cardiothoracic nursing.
She became Chief Nurse and Director of Infection Prevention and Control at St George's University Hospitals NHS Foundation Trust in February 2017.
Avey has a postgraduate diploma in health services management and a masters in public administration. She is also Vice President of the Florence Nightingale Foundation and honorary Vice President of The Nightingale Fellowship.
She is also Guy's and St Thomas':
- Director of Patient Experience
- executive lead for adults' and children's safeguarding
- executive lead for infection, prevention and control
Lawrence was appointed Deputy Chief Executive in March 2020.
Before joining Guy's and St Thomas' he was Director of Strategy, Planning and Performance at University Hospitals Birmingham NHS Foundation Trust.
Lawrence has held a wide range of healthcare leadership roles, both in the UK and abroad. He also worked at the Department of Health in the offices of both the Secretary of State and the NHS Chief Executive and was managing director of the Shelford Group.
Jo joined the Heart, Lung and Critical Care Clinical Group in December 2021 as director of nursing.
Before joining the clinical group, Jo served in a range of roles at Guy’s and St Thomas’ NHS Foundation Trust. Starting at the Trust in August 2015 as deputy head of nursing, she went on to serve as director of nursing adult services, and then as director of the then cardiovascular, respiratory and critical care clinical group. Her remit has spanned areas including critical care, patient experience, workforce development and nutrition.
Jo qualified as a registered nurse in 1996, before going on to complete a degree in clinical practice, and a masters in healthcare leadership.
In 2015, she was awarded the Senior Leadership award by the NHS Leadership Academy.
Robert joined Harefield Hospital in 1995, having previously worked in community and general hospital services.
Following the merger of Royal Brompton Hospital and Harefield Hospital in 1998, he became site director at Harefield and, in 2001, deputy director of operations for Royal Brompton and Harefield hospitals.
Robert has also fulfilled the roles of director of governance and quality (2003 to 2006) and director of planning and strategy (2006 to 2009). In the latter post he was responsible for the Trust’s foundation trust application.
He was appointed to the role of chief operating officer in 2008 and director of development and partnerships in 2018, and now serves as director of operations for the Heart, Lung and Critical Care Clinical Group
Dr Richard Grocott-Mason has been a consultant cardiologist for over 19 years and has led the transformation of clinical services to help deliver large scale care for patients with heart and lung conditions. He was appointed chief executive of the Heart, Lung and Critical Care Clinical Group in February 2021.
Dr Grocott-Mason graduated from Jesus College, Oxford and St Thomas’ Hospital Medical School, London, qualifying in 1986. He has been a consultant cardiologist since 1999, initially at Harefield Hospital and Hillingdon Hospital, where he was also joint medical director and responsible officer, before joining Royal Brompton and Harefield hospitals full time in 2014.
In December 2015, Dr Grocott-Mason was appointed interim medical director and responsible officer of Royal Brompton and Harefield hospitals. He was appointed to the permanent post in 2016.
In July 2019, Dr Grocott-Mason was appointed managing director of the RBH-KHP Partnership, a role which he held until November 2020.
Dr Grocott-Mason is an interventional cardiologist performing coronary angioplasty as part of the team providing the primary angioplasty service at Harefield Hospital's heart attack centre. His adult cardiology experience includes assessment of coronary artery disease, valve disease and heart failure.
Dr Mark Mason is a consultant cardiologist at Harefield Hospital with expertise in coronary intervention, formerly the hospital's divisional director for heart. He was seconded to the role of medical director at Royal Brompton and Harefield hospitals in July 2019, before being appointed to the permanent post.
Dr Mason is nationally recognised as a specialist in pacing lead extraction and has been a specialist advisor to the National Institute for Health and Care Excellence (NICE) on the use of laser sheaths to remove pacing leads.
Dr Mason has played a key role in developing the nationally acclaimed primary angioplasty programme at Harefield Hospital. He has also developed one of the busiest pacing services in the UK, delivering a complete range of pacing implantation and extraction techniques.
He is actively involved in developing innovative pathways to make smoother transitions between primary care and secondary/tertiary care, to improve the patient journey at both a local and regional level.
He is also a member of the Pan-London Arrhythmia Group looking to improve both elective and emergency care of patients with arrhythmias.
Trevor joined Royal Brompton and Harefield hospitals in August 2018 as deputy director of finance, at that time with 18 years of experience as a provider hospital deputy director of finance, and 28 years of experience within NHS Finance.
Trevor started as an assistant management account at the Royal Free Hospital in Hampstead in April 1990, spending 5 years at Royal Free, followed by 5 years at Great Ormond Street Hospital (GOSH), 17 years at Hillingdon Hospital, and 1 year at the Royal National Orthopaedic Hospital. Trevor gradually gained promotion within the financial management teams during this period, before being appointed deputy director of finance at Hillingdon Hospital in 2000.
Following the merger of Royal Brompton and Harefield hospitals with Guy's and St Thomas' NHS Foundation Trust in February 2021, Trevor was initially the associate director of finance for the Royal Brompton and Harefield Clinical Group. Following reconfiguration of Clinical Groups, Trevor became the associate director of finance for the Heart, Lung and Critical Care Clinical Group in April 2022.
Trevor has been a full member of the Association of Chartered Certified Accounts (ACCA) since 1999, and a Fellow of the Association since 2004
Simon joined the Board in February 2021 having been a non-executive director at Royal Brompton and Harefield NHS Foundation Trust since August 2017.
Simon was a chartered accountant and partner at PricewaterhouseCoopers LLP (PwC), where his career spanned more than 30 years. He has a depth of expertise in finance and audit, as well as a thorough understanding of governance across a range of sectors, technical rigour and board experience at the highest level.
Simon is also:
- a trustee at Jewish Care, a charity providing residential and day care facilities
- a member of council at the Royal Academy of Arts
- non-executive director of Bevan Brittan LLP a national law firm
- a non-executive director of Otsuka Pharmaceutical Europe Limited
Dr Felicity Harvey joined the Guy's and St Thomas' Board in September 2016. She was director general for Public and International Health, until her retirement from the civil service in June 2016. Prior to that, she was director of the Prime Minister’s Delivery Unit.
After qualifying in medicine in 1980 at St Bartholomew’s Medical College, London, she completed an International MBA.
Her previous roles include private secretary to the Chief Medical Officer and Head of Medicines, Pharmacy and Industry Group at the Department of Health.
Sally joined the Board in February 2021 having been a non-executive director and Chair at Royal Brompton and Harefield NHS Foundation Trust.
She became a life peer in 2001.
She has served as Minister of State in the Cabinet Office, Political Secretary to the Prime Minister and Director of Government Relations at 10 Downing Street, Chair of OFSTED and board member of the Olympic Delivery Authority.
Sally is Master of Fitzwilliam College, Cambridge, a post she has held since 2019. Sally chairs the Royal Brompton and Harefield Clinical Group Board.
Ian joined the Trust following the merger with Royal Brompton and Harefield NHS Foundation Trust. He joined Royal Brompton and Harefield in 2020 as a non-executive director.
He has been a senior executive with over 30 years' experience across the public and private sector. His previous roles include interim chief executive of the Government Property Agency, where he was asked by the Cabinet Office to set up and manage central Government's £3bn office, warehouse and science estate.
He was also a group property director of Kingfisher PLC where he set the strategy for their capital investment programme and retail distribution portfolio of 1,000 stores across ten countries.
Ian has also been a member of the board of HM Courts and Tribunals Service and the Queen Victoria Hospital NHS Foundation Trust in East Grinstead.
Janet started her career with BP, where she spent 21 years, before moving to North American conglomerate Seagram as organisational capability director for Europe, Middle East and Africa.
After Seagram was taken over by Diageo and Pernod Ricard in 2002, Janet was invited to join Diageo’s management team as HR director for global corporate functions. She later became the company’s global talent and organisation strategy director.
Janet spent 10 years with the business, before leaving to become HR director for EDF Energy in the UK. She became responsible for a range of HR issues, including health, safety and wellbeing.
Janet retired in 2017 and has since become a trustee of the Canal & River Trust. She joined Royal Brompton & Harefield NHS Foundation Trust on December 1st 2018, and, since its merger with Guy's and St Thomas' NHS Foundation Trust, serves as a non-executive advisor.
Until 2018, Peter was a consultant anaesthetist at University Hospital Birmingham and Honorary Professor at the University of Birmingham. He also undertook medical examiner duties. In the past, he has served on hospital boards in both executive and non-executive roles, and has a major interest in medical ethics and medical safety.
During his career he has served on a number of national bodies, such as the GMC and the Bar Standards Board, and from 2007-2009 as joint clinical lead for unscheduled care for NHS London.
Peter was also president of the Royal College of Anaesthetists (2002-2003) and chair of the Academy of Medical Royal Colleges (2002-2004). He established and chaired a Home Office ethics group to manage the ethical aspects of forensic DNA analysis (2008-2010), and more recently was the independent hospital consultant advisor to the two Mid-Staffs inquiries.
In 2014, he was appointed by the Home Office to lead an enquiry into forensic pathology services in England and Wales, and has recently led a review of ‘age and the anaesthetist’ for the Association of Anaesthetists of Great Britain and Ireland. Peter joined Royal Brompton & Harefield NHS Foundation Trust on 26 February 2019, and, since its merger with Guy's and St Thomas' NHS Foundation Trust, serves as a non-executive advisor.
Professor Bernard Keavney has twenty years’ experience as a consultant cardiologist, specialising in the diagnosis and treatment of coronary artery disease, inherited cardiovascular conditions, and heart disease in pregnancy.
Currently British Heart Foundation Professor of Cardiovascular Medicine and a consultant cardiologist at Manchester University NHS Foundation Trust, Bernard’s research career at the Universities of Oxford, Newcastle, and Manchester has seen him contribute widely to studies involving genetic cardiovascular diseases, including the first genome-wide association studies of congenital heart disease.
Bernard has served in several advisory roles in organisations such as the UK Biobank, the UK Government’s 100,000 Genomes Project, and the Medical Research Council.